nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2D6—Lomustine—brain cancer	0.0847	0.187	CbGbCtD
Desipramine—CYP1A2—Carmustine—brain cancer	0.0838	0.185	CbGbCtD
Desipramine—CYP2D6—Hydroxyurea—brain cancer	0.0642	0.142	CbGbCtD
Desipramine—CYP3A4—Temozolomide—brain cancer	0.0633	0.14	CbGbCtD
Desipramine—CYP3A4—Lomustine—brain cancer	0.0538	0.119	CbGbCtD
Desipramine—CYP2E1—Etoposide—brain cancer	0.0429	0.0949	CbGbCtD
Desipramine—CYP1A2—Etoposide—brain cancer	0.0248	0.0549	CbGbCtD
Desipramine—ABCB1—Etoposide—brain cancer	0.0217	0.048	CbGbCtD
Desipramine—HTR2C—choroid plexus—brain cancer	0.015	0.0755	CbGeAlD
Desipramine—CYP3A4—Etoposide—brain cancer	0.013	0.0288	CbGbCtD
Desipramine—HTR2A—choroid plexus—brain cancer	0.00753	0.0379	CbGeAlD
Desipramine—HRH1—nose—brain cancer	0.00581	0.0292	CbGeAlD
Desipramine—SLC6A3—telencephalic ventricle—brain cancer	0.00455	0.0229	CbGeAlD
Desipramine—HTR2C—telencephalic ventricle—brain cancer	0.0044	0.0221	CbGeAlD
Desipramine—HTR2A—trigeminal nerve—brain cancer	0.00381	0.0191	CbGeAlD
Desipramine—HTR2A—cerebellar cortex—brain cancer	0.00379	0.0191	CbGeAlD
Desipramine—HTR1A—telencephalic ventricle—brain cancer	0.0037	0.0186	CbGeAlD
Desipramine—Disorientation—Lomustine—brain cancer	0.00364	0.0176	CcSEcCtD
Desipramine—Tongue discolouration—Temozolomide—brain cancer	0.00356	0.0172	CcSEcCtD
Desipramine—Petechiae—Procarbazine—brain cancer	0.00346	0.0167	CcSEcCtD
Desipramine—HTR2A—vein—brain cancer	0.00344	0.0173	CbGeAlD
Desipramine—DRD2—telencephalic ventricle—brain cancer	0.00335	0.0168	CbGeAlD
Desipramine—Nocturia—Procarbazine—brain cancer	0.00307	0.0148	CcSEcCtD
Desipramine—Ataxia—Lomustine—brain cancer	0.00306	0.0148	CcSEcCtD
Desipramine—SLC6A3—ganglion—brain cancer	0.00283	0.0142	CbGeAlD
Desipramine—SLC22A1—ganglion—brain cancer	0.00279	0.014	CbGeAlD
Desipramine—Nightmare—Procarbazine—brain cancer	0.00275	0.0133	CcSEcCtD
Desipramine—HTR2C—ganglion—brain cancer	0.00274	0.0138	CbGeAlD
Desipramine—HTR2A—cranial nerve—brain cancer	0.00271	0.0136	CbGeAlD
Desipramine—HTR2A—pons—brain cancer	0.00268	0.0135	CbGeAlD
Desipramine—SLC6A4—ganglion—brain cancer	0.0026	0.013	CbGeAlD
Desipramine—Gynaecomastia—Procarbazine—brain cancer	0.00255	0.0123	CcSEcCtD
Desipramine—Stomatitis—Lomustine—brain cancer	0.00244	0.0118	CcSEcCtD
Desipramine—SMPD1—telencephalon—brain cancer	0.0024	0.0121	CbGeAlD
Desipramine—Disorientation—Procarbazine—brain cancer	0.00231	0.0112	CcSEcCtD
Desipramine—Vascular purpura—Procarbazine—brain cancer	0.00231	0.0112	CcSEcCtD
Desipramine—HTR1A—ganglion—brain cancer	0.0023	0.0116	CbGeAlD
Desipramine—SLC6A2—ganglion—brain cancer	0.00229	0.0115	CbGeAlD
Desipramine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00228	0.011	CcSEcCtD
Desipramine—HTR2A—telencephalic ventricle—brain cancer	0.00221	0.0111	CbGeAlD
Desipramine—SLC6A3—hindbrain—brain cancer	0.00215	0.0108	CbGeAlD
Desipramine—Purpura—Procarbazine—brain cancer	0.00214	0.0104	CcSEcCtD
Desipramine—Petechiae—Temozolomide—brain cancer	0.00209	0.0101	CcSEcCtD
Desipramine—DRD2—ganglion—brain cancer	0.00208	0.0105	CbGeAlD
Desipramine—SMPD1—gonad—brain cancer	0.002	0.0101	CbGeAlD
Desipramine—Alopecia—Lomustine—brain cancer	0.00199	0.00961	CcSEcCtD
Desipramine—SLC6A4—hindbrain—brain cancer	0.00197	0.0099	CbGeAlD
Desipramine—Ataxia—Procarbazine—brain cancer	0.00194	0.00939	CcSEcCtD
Desipramine—HTR2A—pineal body—brain cancer	0.00191	0.00962	CbGeAlD
Desipramine—Coordination abnormal—Carmustine—brain cancer	0.00181	0.00876	CcSEcCtD
Desipramine—Disorientation—Hydroxyurea—brain cancer	0.00179	0.00864	CcSEcCtD
Desipramine—Eosinophilia—Procarbazine—brain cancer	0.00177	0.00854	CcSEcCtD
Desipramine—Coordination abnormal—Temozolomide—brain cancer	0.00175	0.00847	CcSEcCtD
Desipramine—HTR1A—hindbrain—brain cancer	0.00175	0.00879	CbGeAlD
Desipramine—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00172	0.00831	CcSEcCtD
Desipramine—Tingling sensation—Etoposide—brain cancer	0.00171	0.00828	CcSEcCtD
Desipramine—SMPD1—spinal cord—brain cancer	0.00168	0.00845	CbGeAlD
Desipramine—Numbness—Etoposide—brain cancer	0.00166	0.00803	CcSEcCtD
Desipramine—Pollakiuria—Procarbazine—brain cancer	0.00165	0.00797	CcSEcCtD
Desipramine—Gynaecomastia—Carmustine—brain cancer	0.00159	0.0077	CcSEcCtD
Desipramine—Drowsiness—Procarbazine—brain cancer	0.00159	0.00769	CcSEcCtD
Desipramine—Sensory loss—Etoposide—brain cancer	0.00159	0.00768	CcSEcCtD
Desipramine—DRD2—hindbrain—brain cancer	0.00158	0.00794	CbGeAlD
Desipramine—Thrombocytopenia—Lomustine—brain cancer	0.00157	0.00757	CcSEcCtD
Desipramine—Neuropathy peripheral—Procarbazine—brain cancer	0.00156	0.00754	CcSEcCtD
Desipramine—Jaundice—Procarbazine—brain cancer	0.00155	0.0075	CcSEcCtD
Desipramine—Stomatitis—Procarbazine—brain cancer	0.00155	0.0075	CcSEcCtD
Desipramine—Anorexia—Lomustine—brain cancer	0.00152	0.00737	CcSEcCtD
Desipramine—SMPD1—endocrine gland—brain cancer	0.00151	0.00761	CbGeAlD
Desipramine—SMPD1—head—brain cancer	0.00149	0.00751	CbGeAlD
Desipramine—Body temperature increased—Carboplatin—brain cancer	0.00144	0.00698	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00144	0.00694	CcSEcCtD
Desipramine—Hallucination—Procarbazine—brain cancer	0.00142	0.00687	CcSEcCtD
Desipramine—Vascular purpura—Temozolomide—brain cancer	0.0014	0.00675	CcSEcCtD
Desipramine—Decreased appetite—Lomustine—brain cancer	0.00139	0.00672	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Etoposide—brain cancer	0.00138	0.00665	CcSEcCtD
Desipramine—HTR2A—ganglion—brain cancer	0.00137	0.00691	CbGeAlD
Desipramine—SMPD1—central nervous system—brain cancer	0.00136	0.00686	CbGeAlD
Desipramine—SMPD1—cerebellum—brain cancer	0.00133	0.0067	CbGeAlD
Desipramine—Flushing—Procarbazine—brain cancer	0.00133	0.00641	CcSEcCtD
Desipramine—Purpura—Temozolomide—brain cancer	0.0013	0.00626	CcSEcCtD
Desipramine—Arrhythmia—Procarbazine—brain cancer	0.00128	0.00617	CcSEcCtD
Desipramine—CHRM4—head—brain cancer	0.00127	0.00639	CbGeAlD
Desipramine—Body temperature increased—Lomustine—brain cancer	0.00126	0.00611	CcSEcCtD
Desipramine—Alopecia—Procarbazine—brain cancer	0.00126	0.0061	CcSEcCtD
Desipramine—Weight increased—Hydroxyurea—brain cancer	0.00126	0.00608	CcSEcCtD
Desipramine—Drowsiness—Hydroxyurea—brain cancer	0.00123	0.00595	CcSEcCtD
Desipramine—SLC6A3—brainstem—brain cancer	0.00123	0.00619	CbGeAlD
Desipramine—CYP2C18—endocrine gland—brain cancer	0.00123	0.00619	CbGeAlD
Desipramine—Ataxia—Carmustine—brain cancer	0.00121	0.00587	CcSEcCtD
Desipramine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00121	0.00584	CcSEcCtD
Desipramine—Stomatitis—Hydroxyurea—brain cancer	0.0012	0.0058	CcSEcCtD
Desipramine—Liver function test abnormal—Carmustine—brain cancer	0.00119	0.00577	CcSEcCtD
Desipramine—HTR2C—brainstem—brain cancer	0.00119	0.00598	CbGeAlD
Desipramine—HTR2A—endothelium—brain cancer	0.00118	0.00595	CbGeAlD
Desipramine—Ataxia—Temozolomide—brain cancer	0.00117	0.00567	CcSEcCtD
Desipramine—Tremor—Procarbazine—brain cancer	0.00117	0.00563	CcSEcCtD
Desipramine—CHRM4—central nervous system—brain cancer	0.00116	0.00584	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00115	0.00555	CcSEcCtD
Desipramine—SLC6A4—brainstem—brain cancer	0.00113	0.00567	CbGeAlD
Desipramine—Hallucination—Hydroxyurea—brain cancer	0.0011	0.00532	CcSEcCtD
Desipramine—CHRM2—telencephalon—brain cancer	0.0011	0.00551	CbGeAlD
Desipramine—SLC6A3—telencephalon—brain cancer	0.00109	0.00549	CbGeAlD
Desipramine—HTR2A—blood vessel—brain cancer	0.00109	0.00549	CbGeAlD
Desipramine—SMPD1—brain—brain cancer	0.00108	0.00544	CbGeAlD
Desipramine—Convulsion—Procarbazine—brain cancer	0.00108	0.00521	CcSEcCtD
Desipramine—SLC22A1—telencephalon—brain cancer	0.00108	0.00541	CbGeAlD
Desipramine—Hypertension—Procarbazine—brain cancer	0.00107	0.00519	CcSEcCtD
Desipramine—HTR2C—telencephalon—brain cancer	0.00106	0.00531	CbGeAlD
Desipramine—Anxiety—Procarbazine—brain cancer	0.00106	0.0051	CcSEcCtD
Desipramine—HTR2A—hindbrain—brain cancer	0.00104	0.00524	CbGeAlD
Desipramine—ADRB1—telencephalon—brain cancer	0.00104	0.00521	CbGeAlD
Desipramine—Dry mouth—Procarbazine—brain cancer	0.00104	0.005	CcSEcCtD
Desipramine—Confusional state—Procarbazine—brain cancer	0.00102	0.00495	CcSEcCtD
Desipramine—Vomiting—Lomustine—brain cancer	0.00102	0.00491	CcSEcCtD
Desipramine—Oedema—Procarbazine—brain cancer	0.00102	0.00491	CcSEcCtD
Desipramine—HTR1A—brainstem—brain cancer	0.001	0.00504	CbGeAlD
Desipramine—SLC6A4—telencephalon—brain cancer	0.001	0.00503	CbGeAlD
Desipramine—CHRM1—telencephalon—brain cancer	0.000997	0.00501	CbGeAlD
Desipramine—Pollakiuria—Temozolomide—brain cancer	0.000997	0.00482	CcSEcCtD
Desipramine—CHRM5—head—brain cancer	0.000994	0.005	CbGeAlD
Desipramine—Erectile dysfunction—Temozolomide—brain cancer	0.000994	0.0048	CcSEcCtD
Desipramine—Thrombocytopenia—Procarbazine—brain cancer	0.000994	0.0048	CcSEcCtD
Desipramine—SLC6A2—brainstem—brain cancer	0.000993	0.00499	CbGeAlD
Desipramine—Depression—Carmustine—brain cancer	0.000993	0.0048	CcSEcCtD
Desipramine—Tachycardia—Procarbazine—brain cancer	0.000991	0.00479	CcSEcCtD
Desipramine—Weight increased—Temozolomide—brain cancer	0.000982	0.00475	CcSEcCtD
Desipramine—Alopecia—Hydroxyurea—brain cancer	0.000977	0.00472	CcSEcCtD
Desipramine—Neuropathy peripheral—Carmustine—brain cancer	0.000976	0.00472	CcSEcCtD
Desipramine—Stomatitis—Carmustine—brain cancer	0.000971	0.00469	CcSEcCtD
Desipramine—Anorexia—Procarbazine—brain cancer	0.000968	0.00468	CcSEcCtD
Desipramine—Depression—Temozolomide—brain cancer	0.000959	0.00464	CcSEcCtD
Desipramine—Nausea—Lomustine—brain cancer	0.00095	0.00459	CcSEcCtD
Desipramine—CYP2D6—hindbrain—brain cancer	0.000949	0.00477	CbGeAlD
Desipramine—Hypotension—Procarbazine—brain cancer	0.000948	0.00458	CcSEcCtD
Desipramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000943	0.00456	CcSEcCtD
Desipramine—Stomatitis—Temozolomide—brain cancer	0.000938	0.00453	CcSEcCtD
Desipramine—CHRM4—brain—brain cancer	0.000922	0.00463	CbGeAlD
Desipramine—SLC22A4—pituitary gland—brain cancer	0.00092	0.00463	CbGeAlD
Desipramine—Insomnia—Procarbazine—brain cancer	0.000918	0.00444	CcSEcCtD
Desipramine—Paraesthesia—Procarbazine—brain cancer	0.000911	0.00441	CcSEcCtD
Desipramine—CHRM5—central nervous system—brain cancer	0.000907	0.00456	CbGeAlD
Desipramine—DRD2—brainstem—brain cancer	0.000905	0.00455	CbGeAlD
Desipramine—Somnolence—Procarbazine—brain cancer	0.000902	0.00436	CcSEcCtD
Desipramine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000893	0.00432	CcSEcCtD
Desipramine—CHRM3—telencephalon—brain cancer	0.000893	0.00449	CbGeAlD
Desipramine—Hallucination—Carmustine—brain cancer	0.000889	0.0043	CcSEcCtD
Desipramine—Hypoaesthesia—Carmustine—brain cancer	0.000889	0.0043	CcSEcCtD
Desipramine—HTR1A—telencephalon—brain cancer	0.000889	0.00447	CbGeAlD
Desipramine—Decreased appetite—Procarbazine—brain cancer	0.000882	0.00426	CcSEcCtD
Desipramine—SLC6A2—telencephalon—brain cancer	0.000882	0.00443	CbGeAlD
Desipramine—Fatigue—Procarbazine—brain cancer	0.000875	0.00423	CcSEcCtD
Desipramine—Malaise—Hydroxyurea—brain cancer	0.000868	0.0042	CcSEcCtD
Desipramine—Constipation—Procarbazine—brain cancer	0.000868	0.0042	CcSEcCtD
Desipramine—Hepatitis—Temozolomide—brain cancer	0.000864	0.00417	CcSEcCtD
Desipramine—Hypoaesthesia—Temozolomide—brain cancer	0.000859	0.00415	CcSEcCtD
Desipramine—Hallucination—Temozolomide—brain cancer	0.000859	0.00415	CcSEcCtD
Desipramine—SLC22A3—gonad—brain cancer	0.000859	0.00432	CbGeAlD
Desipramine—Feeling abnormal—Procarbazine—brain cancer	0.000836	0.00404	CcSEcCtD
Desipramine—Convulsion—Hydroxyurea—brain cancer	0.000834	0.00403	CcSEcCtD
Desipramine—HTR2C—medulla oblongata—brain cancer	0.00083	0.00417	CbGeAlD
Desipramine—Flushing—Carmustine—brain cancer	0.00083	0.00401	CcSEcCtD
Desipramine—ORM1—spinal cord—brain cancer	0.000823	0.00414	CbGeAlD
Desipramine—Discomfort—Hydroxyurea—brain cancer	0.00081	0.00391	CcSEcCtD
Desipramine—Urticaria—Procarbazine—brain cancer	0.000806	0.0039	CcSEcCtD
Desipramine—Tinnitus—Temozolomide—brain cancer	0.000805	0.00389	CcSEcCtD
Desipramine—DRD2—telencephalon—brain cancer	0.000803	0.00404	CbGeAlD
Desipramine—Body temperature increased—Procarbazine—brain cancer	0.000802	0.00388	CcSEcCtD
Desipramine—Abdominal pain—Procarbazine—brain cancer	0.000802	0.00388	CcSEcCtD
Desipramine—Flushing—Temozolomide—brain cancer	0.000802	0.00387	CcSEcCtD
Desipramine—Arrhythmia—Carmustine—brain cancer	0.000799	0.00386	CcSEcCtD
Desipramine—SLC22A4—spinal cord—brain cancer	0.000792	0.00398	CbGeAlD
Desipramine—Alopecia—Carmustine—brain cancer	0.00079	0.00382	CcSEcCtD
Desipramine—Oedema—Hydroxyurea—brain cancer	0.000786	0.0038	CcSEcCtD
Desipramine—SLC6A3—midbrain—brain cancer	0.000785	0.00395	CbGeAlD
Desipramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000769	0.00372	CcSEcCtD
Desipramine—SLC6A3—spinal cord—brain cancer	0.000766	0.00385	CbGeAlD
Desipramine—Alopecia—Temozolomide—brain cancer	0.000763	0.00369	CcSEcCtD
Desipramine—Acute coronary syndrome—Etoposide—brain cancer	0.000759	0.00367	CcSEcCtD
Desipramine—HTR2C—midbrain—brain cancer	0.000758	0.00381	CbGeAlD
Desipramine—Myocardial infarction—Etoposide—brain cancer	0.000755	0.00365	CcSEcCtD
Desipramine—Neuropathy peripheral—Etoposide—brain cancer	0.000755	0.00365	CcSEcCtD
Desipramine—Stomatitis—Etoposide—brain cancer	0.000751	0.00363	CcSEcCtD
Desipramine—Jaundice—Etoposide—brain cancer	0.000751	0.00363	CcSEcCtD
Desipramine—Anorexia—Hydroxyurea—brain cancer	0.000749	0.00362	CcSEcCtD
Desipramine—Carbamazepine—CYP2C9—brain cancer	0.000742	0.188	CrCbGaD
Desipramine—ORM1—endocrine gland—brain cancer	0.000741	0.00373	CbGeAlD
Desipramine—HTR2C—spinal cord—brain cancer	0.00074	0.00372	CbGeAlD
Desipramine—Dysgeusia—Temozolomide—brain cancer	0.000736	0.00356	CcSEcCtD
Desipramine—SLC6A2—gonad—brain cancer	0.000736	0.0037	CbGeAlD
Desipramine—Vision blurred—Carmustine—brain cancer	0.000733	0.00354	CcSEcCtD
Desipramine—Tremor—Carmustine—brain cancer	0.000729	0.00352	CcSEcCtD
Desipramine—Asthenia—Procarbazine—brain cancer	0.000728	0.00352	CcSEcCtD
Desipramine—CHRM5—brain—brain cancer	0.00072	0.00362	CbGeAlD
Desipramine—SLC6A4—midbrain—brain cancer	0.000719	0.00362	CbGeAlD
Desipramine—Agranulocytosis—Etoposide—brain cancer	0.000719	0.00347	CcSEcCtD
Desipramine—Pruritus—Procarbazine—brain cancer	0.000718	0.00347	CcSEcCtD
Desipramine—CYP2A6—cerebellum—brain cancer	0.000717	0.0036	CbGeAlD
Desipramine—ABCB1—blood vessel—brain cancer	0.000716	0.0036	CbGeAlD
Desipramine—Agitation—Carmustine—brain cancer	0.000715	0.00346	CcSEcCtD
Desipramine—Vision blurred—Temozolomide—brain cancer	0.000709	0.00343	CcSEcCtD
Desipramine—Tremor—Temozolomide—brain cancer	0.000705	0.0034	CcSEcCtD
Desipramine—SLC6A4—spinal cord—brain cancer	0.000702	0.00353	CbGeAlD
Desipramine—Somnolence—Hydroxyurea—brain cancer	0.000698	0.00338	CcSEcCtD
Desipramine—Ill-defined disorder—Temozolomide—brain cancer	0.000698	0.00337	CcSEcCtD
Desipramine—Diarrhoea—Procarbazine—brain cancer	0.000694	0.00336	CcSEcCtD
Desipramine—SLC6A2—medulla oblongata—brain cancer	0.000693	0.00348	CbGeAlD
Desipramine—Dyspepsia—Hydroxyurea—brain cancer	0.000691	0.00334	CcSEcCtD
Desipramine—CHRM2—endocrine gland—brain cancer	0.000691	0.00347	CbGeAlD
Desipramine—Agitation—Temozolomide—brain cancer	0.000691	0.00334	CcSEcCtD
Desipramine—Hypoaesthesia—Etoposide—brain cancer	0.000688	0.00332	CcSEcCtD
Desipramine—Decreased appetite—Hydroxyurea—brain cancer	0.000683	0.0033	CcSEcCtD
Desipramine—CHRM2—head—brain cancer	0.000682	0.00343	CbGeAlD
Desipramine—SLC6A3—head—brain cancer	0.00068	0.00342	CbGeAlD
Desipramine—SLC22A1—endocrine gland—brain cancer	0.000679	0.00341	CbGeAlD
Desipramine—Malaise—Temozolomide—brain cancer	0.000678	0.00328	CcSEcCtD
Desipramine—Fatigue—Hydroxyurea—brain cancer	0.000677	0.00327	CcSEcCtD
Desipramine—Convulsion—Carmustine—brain cancer	0.000674	0.00326	CcSEcCtD
Desipramine—Hypertension—Carmustine—brain cancer	0.000672	0.00325	CcSEcCtD
Desipramine—Constipation—Hydroxyurea—brain cancer	0.000672	0.00325	CcSEcCtD
Desipramine—Dizziness—Procarbazine—brain cancer	0.000671	0.00324	CcSEcCtD
Desipramine—SLC22A1—head—brain cancer	0.00067	0.00337	CbGeAlD
Desipramine—ORM1—central nervous system—brain cancer	0.000668	0.00336	CbGeAlD
Desipramine—Palpitations—Temozolomide—brain cancer	0.000665	0.00321	CcSEcCtD
Desipramine—Anxiety—Carmustine—brain cancer	0.00066	0.00319	CcSEcCtD
Desipramine—HTR2C—head—brain cancer	0.000658	0.00331	CbGeAlD
Desipramine—DRD2—pituitary gland—brain cancer	0.000654	0.00329	CbGeAlD
Desipramine—ADRB1—endocrine gland—brain cancer	0.000654	0.00329	CbGeAlD
Desipramine—Convulsion—Temozolomide—brain cancer	0.000652	0.00315	CcSEcCtD
Desipramine—Hypertension—Temozolomide—brain cancer	0.000649	0.00314	CcSEcCtD
Desipramine—SLC22A3—endocrine gland—brain cancer	0.000649	0.00326	CbGeAlD
Desipramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000647	0.00313	CcSEcCtD
Desipramine—ADRB1—head—brain cancer	0.000645	0.00324	CbGeAlD
Desipramine—Vomiting—Procarbazine—brain cancer	0.000645	0.00312	CcSEcCtD
Desipramine—Flushing—Etoposide—brain cancer	0.000641	0.0031	CcSEcCtD
Desipramine—SLC22A3—head—brain cancer	0.000641	0.00322	CbGeAlD
Desipramine—Confusional state—Carmustine—brain cancer	0.00064	0.00309	CcSEcCtD
Desipramine—Rash—Procarbazine—brain cancer	0.00064	0.00309	CcSEcCtD
Desipramine—Dermatitis—Procarbazine—brain cancer	0.000639	0.00309	CcSEcCtD
Desipramine—HTR1A—midbrain—brain cancer	0.000638	0.00321	CbGeAlD
Desipramine—Anxiety—Temozolomide—brain cancer	0.000638	0.00308	CcSEcCtD
Desipramine—Headache—Procarbazine—brain cancer	0.000636	0.00307	CcSEcCtD
Desipramine—Oedema—Carmustine—brain cancer	0.000635	0.00307	CcSEcCtD
Desipramine—HRH1—telencephalon—brain cancer	0.000634	0.00319	CbGeAlD
Desipramine—Discomfort—Temozolomide—brain cancer	0.000633	0.00306	CcSEcCtD
Desipramine—SLC6A4—endocrine gland—brain cancer	0.000632	0.00318	CbGeAlD
Desipramine—CHRM1—endocrine gland—brain cancer	0.000629	0.00316	CbGeAlD
Desipramine—SLC22A4—cerebellum—brain cancer	0.000628	0.00316	CbGeAlD
Desipramine—Dry mouth—Temozolomide—brain cancer	0.000626	0.00303	CcSEcCtD
Desipramine—SLC6A4—head—brain cancer	0.000623	0.00313	CbGeAlD
Desipramine—HTR1A—spinal cord—brain cancer	0.000623	0.00313	CbGeAlD
Desipramine—CHRM2—central nervous system—brain cancer	0.000623	0.00313	CbGeAlD
Desipramine—Thrombocytopenia—Carmustine—brain cancer	0.000622	0.00301	CcSEcCtD
Desipramine—CHRM1—head—brain cancer	0.000621	0.00312	CbGeAlD
Desipramine—SLC6A3—central nervous system—brain cancer	0.000621	0.00312	CbGeAlD
Desipramine—Body temperature increased—Hydroxyurea—brain cancer	0.000621	0.003	CcSEcCtD
Desipramine—Tachycardia—Carmustine—brain cancer	0.00062	0.003	CcSEcCtD
Desipramine—Confusional state—Temozolomide—brain cancer	0.000619	0.00299	CcSEcCtD
Desipramine—Oedema—Temozolomide—brain cancer	0.000614	0.00297	CcSEcCtD
Desipramine—SLC22A1—central nervous system—brain cancer	0.000612	0.00308	CbGeAlD
Desipramine—Nortriptyline—CYP2C9—brain cancer	0.000611	0.155	CrCbGaD
Desipramine—Alopecia—Etoposide—brain cancer	0.000611	0.00295	CcSEcCtD
Desipramine—CYP2E1—telencephalon—brain cancer	0.00061	0.00306	CbGeAlD
Desipramine—SLC22A5—pituitary gland—brain cancer	0.000609	0.00306	CbGeAlD
Desipramine—SLC6A3—cerebellum—brain cancer	0.000607	0.00305	CbGeAlD
Desipramine—Anorexia—Carmustine—brain cancer	0.000605	0.00293	CcSEcCtD
Desipramine—Nausea—Procarbazine—brain cancer	0.000603	0.00291	CcSEcCtD
Desipramine—Thrombocytopenia—Temozolomide—brain cancer	0.000601	0.0029	CcSEcCtD
Desipramine—HTR2C—central nervous system—brain cancer	0.0006	0.00302	CbGeAlD
Desipramine—HTR2A—brainstem—brain cancer	0.000597	0.003	CbGeAlD
Desipramine—Hypotension—Carmustine—brain cancer	0.000593	0.00287	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—brain cancer	0.000589	0.00285	CcSEcCtD
Desipramine—ADRB1—central nervous system—brain cancer	0.000589	0.00296	CbGeAlD
Desipramine—SLC22A5—medulla oblongata—brain cancer	0.000588	0.00295	CbGeAlD
Desipramine—Anorexia—Temozolomide—brain cancer	0.000585	0.00283	CcSEcCtD
Desipramine—SLC22A3—central nervous system—brain cancer	0.000585	0.00294	CbGeAlD
Desipramine—CYP2A6—brain—brain cancer	0.000582	0.00293	CbGeAlD
Desipramine—DRD2—midbrain—brain cancer	0.000577	0.0029	CbGeAlD
Desipramine—Trimipramine—CYP2C9—brain cancer	0.000576	0.146	CrCbGaD
Desipramine—Insomnia—Carmustine—brain cancer	0.000574	0.00278	CcSEcCtD
Desipramine—Paraesthesia—Carmustine—brain cancer	0.00057	0.00276	CcSEcCtD
Desipramine—SLC6A4—central nervous system—brain cancer	0.000569	0.00286	CbGeAlD
Desipramine—CHRM1—central nervous system—brain cancer	0.000567	0.00285	CbGeAlD
Desipramine—Somnolence—Carmustine—brain cancer	0.000565	0.00273	CcSEcCtD
Desipramine—Asthenia—Hydroxyurea—brain cancer	0.000564	0.00272	CcSEcCtD
Desipramine—CHRM3—endocrine gland—brain cancer	0.000563	0.00283	CbGeAlD
Desipramine—HTR1A—endocrine gland—brain cancer	0.000561	0.00282	CbGeAlD
Desipramine—Ill-defined disorder—Etoposide—brain cancer	0.000558	0.0027	CcSEcCtD
Desipramine—SLC6A2—endocrine gland—brain cancer	0.000556	0.0028	CbGeAlD
Desipramine—CHRM3—head—brain cancer	0.000556	0.00279	CbGeAlD
Desipramine—Insomnia—Temozolomide—brain cancer	0.000555	0.00268	CcSEcCtD
Desipramine—Promethazine—CYP2C9—brain cancer	0.000554	0.141	CrCbGaD
Desipramine—HTR1A—head—brain cancer	0.000554	0.00278	CbGeAlD
Desipramine—Decreased appetite—Carmustine—brain cancer	0.000552	0.00267	CcSEcCtD
Desipramine—Paraesthesia—Temozolomide—brain cancer	0.000551	0.00266	CcSEcCtD
Desipramine—SLC6A2—head—brain cancer	0.000549	0.00276	CbGeAlD
Desipramine—Doxepin—CYP2C9—brain cancer	0.000549	0.139	CrCbGaD
Desipramine—Somnolence—Temozolomide—brain cancer	0.000546	0.00264	CcSEcCtD
Desipramine—CYP2D6—brainstem—brain cancer	0.000544	0.00273	CbGeAlD
Desipramine—Constipation—Carmustine—brain cancer	0.000543	0.00262	CcSEcCtD
Desipramine—Malaise—Etoposide—brain cancer	0.000543	0.00262	CcSEcCtD
Desipramine—CYP2B6—gonad—brain cancer	0.000542	0.00273	CbGeAlD
Desipramine—Dyspepsia—Temozolomide—brain cancer	0.00054	0.00261	CcSEcCtD
Desipramine—Diarrhoea—Hydroxyurea—brain cancer	0.000537	0.0026	CcSEcCtD
Desipramine—SLC22A5—midbrain—brain cancer	0.000537	0.0027	CbGeAlD
Desipramine—Decreased appetite—Temozolomide—brain cancer	0.000533	0.00258	CcSEcCtD
Desipramine—HTR2A—telencephalon—brain cancer	0.00053	0.00266	CbGeAlD
Desipramine—Fatigue—Temozolomide—brain cancer	0.000529	0.00256	CcSEcCtD
Desipramine—Constipation—Temozolomide—brain cancer	0.000525	0.00254	CcSEcCtD
Desipramine—SLC22A5—spinal cord—brain cancer	0.000524	0.00263	CbGeAlD
Desipramine—Feeling abnormal—Carmustine—brain cancer	0.000523	0.00253	CcSEcCtD
Desipramine—CYP2C19—endocrine gland—brain cancer	0.000523	0.00263	CbGeAlD
Desipramine—Convulsion—Etoposide—brain cancer	0.000521	0.00252	CcSEcCtD
Desipramine—Hypertension—Etoposide—brain cancer	0.000519	0.00251	CcSEcCtD
Desipramine—Dizziness—Hydroxyurea—brain cancer	0.000519	0.00251	CcSEcCtD
Desipramine—SLC22A4—brain—brain cancer	0.00051	0.00256	CbGeAlD
Desipramine—CHRM3—central nervous system—brain cancer	0.000507	0.00255	CbGeAlD
Desipramine—DRD2—endocrine gland—brain cancer	0.000507	0.00255	CbGeAlD
Desipramine—Discomfort—Etoposide—brain cancer	0.000506	0.00245	CcSEcCtD
Desipramine—Feeling abnormal—Temozolomide—brain cancer	0.000506	0.00244	CcSEcCtD
Desipramine—HTR1A—central nervous system—brain cancer	0.000505	0.00254	CbGeAlD
Desipramine—Abdominal pain—Carmustine—brain cancer	0.000502	0.00243	CcSEcCtD
Desipramine—Body temperature increased—Carmustine—brain cancer	0.000502	0.00243	CcSEcCtD
Desipramine—SLC6A2—central nervous system—brain cancer	0.000501	0.00252	CbGeAlD
Desipramine—DRD2—head—brain cancer	0.0005	0.00251	CbGeAlD
Desipramine—Vomiting—Hydroxyurea—brain cancer	0.000499	0.00241	CcSEcCtD
Desipramine—Rash—Hydroxyurea—brain cancer	0.000495	0.00239	CcSEcCtD
Desipramine—Confusional state—Etoposide—brain cancer	0.000495	0.00239	CcSEcCtD
Desipramine—Dermatitis—Hydroxyurea—brain cancer	0.000495	0.00239	CcSEcCtD
Desipramine—CHRM2—brain—brain cancer	0.000494	0.00249	CbGeAlD
Desipramine—HTR1A—cerebellum—brain cancer	0.000494	0.00248	CbGeAlD
Desipramine—SLC6A3—brain—brain cancer	0.000493	0.00248	CbGeAlD
Desipramine—Headache—Hydroxyurea—brain cancer	0.000492	0.00238	CcSEcCtD
Desipramine—Promazine—CYP2C9—brain cancer	0.000488	0.124	CrCbGaD
Desipramine—Urticaria—Temozolomide—brain cancer	0.000488	0.00236	CcSEcCtD
Desipramine—SLC22A1—brain—brain cancer	0.000486	0.00244	CbGeAlD
Desipramine—Body temperature increased—Temozolomide—brain cancer	0.000485	0.00234	CcSEcCtD
Desipramine—Abdominal pain—Temozolomide—brain cancer	0.000485	0.00234	CcSEcCtD
Desipramine—CYP2D6—telencephalon—brain cancer	0.000483	0.00243	CbGeAlD
Desipramine—Thrombocytopenia—Etoposide—brain cancer	0.000481	0.00232	CcSEcCtD
Desipramine—Tachycardia—Etoposide—brain cancer	0.000479	0.00232	CcSEcCtD
Desipramine—CYP2E1—medulla oblongata—brain cancer	0.000479	0.00241	CbGeAlD
Desipramine—HTR2C—brain—brain cancer	0.000477	0.0024	CbGeAlD
Desipramine—Anorexia—Etoposide—brain cancer	0.000468	0.00226	CcSEcCtD
Desipramine—ADRB1—brain—brain cancer	0.000468	0.00235	CbGeAlD
Desipramine—Nausea—Hydroxyurea—brain cancer	0.000467	0.00226	CcSEcCtD
Desipramine—SLC22A3—brain—brain cancer	0.000464	0.00233	CbGeAlD
Desipramine—Hypotension—Etoposide—brain cancer	0.000459	0.00222	CcSEcCtD
Desipramine—DRD2—central nervous system—brain cancer	0.000457	0.0023	CbGeAlD
Desipramine—Asthenia—Carmustine—brain cancer	0.000456	0.0022	CcSEcCtD
Desipramine—SLC6A4—brain—brain cancer	0.000452	0.00227	CbGeAlD
Desipramine—CHRM1—brain—brain cancer	0.00045	0.00226	CbGeAlD
Desipramine—DRD2—cerebellum—brain cancer	0.000446	0.00224	CbGeAlD
Desipramine—HTR2A—gonad—brain cancer	0.000442	0.00222	CbGeAlD
Desipramine—Paraesthesia—Etoposide—brain cancer	0.000441	0.00213	CcSEcCtD
Desipramine—Asthenia—Temozolomide—brain cancer	0.00044	0.00213	CcSEcCtD
Desipramine—Somnolence—Etoposide—brain cancer	0.000437	0.00211	CcSEcCtD
Desipramine—Diarrhoea—Carmustine—brain cancer	0.000435	0.0021	CcSEcCtD
Desipramine—Pruritus—Temozolomide—brain cancer	0.000434	0.0021	CcSEcCtD
Desipramine—HTR2A—pituitary gland—brain cancer	0.000431	0.00217	CbGeAlD
Desipramine—CYP1A2—endocrine gland—brain cancer	0.000427	0.00215	CbGeAlD
Desipramine—CYP2E1—spinal cord—brain cancer	0.000427	0.00215	CbGeAlD
Desipramine—Decreased appetite—Etoposide—brain cancer	0.000427	0.00206	CcSEcCtD
Desipramine—Amitriptyline—CYP2C9—brain cancer	0.000424	0.108	CrCbGaD
Desipramine—Fatigue—Etoposide—brain cancer	0.000423	0.00205	CcSEcCtD
Desipramine—Dizziness—Carmustine—brain cancer	0.00042	0.00203	CcSEcCtD
Desipramine—Constipation—Etoposide—brain cancer	0.00042	0.00203	CcSEcCtD
Desipramine—Diarrhoea—Temozolomide—brain cancer	0.00042	0.00203	CcSEcCtD
Desipramine—HTR2A—medulla oblongata—brain cancer	0.000416	0.00209	CbGeAlD
Desipramine—SLC22A5—cerebellum—brain cancer	0.000416	0.00209	CbGeAlD
Desipramine—CYP2B6—endocrine gland—brain cancer	0.00041	0.00206	CbGeAlD
Desipramine—Dizziness—Temozolomide—brain cancer	0.000406	0.00196	CcSEcCtD
Desipramine—Feeling abnormal—Etoposide—brain cancer	0.000405	0.00196	CcSEcCtD
Desipramine—CYP2B6—head—brain cancer	0.000404	0.00203	CbGeAlD
Desipramine—Vomiting—Carmustine—brain cancer	0.000404	0.00195	CcSEcCtD
Desipramine—CHRM3—brain—brain cancer	0.000403	0.00203	CbGeAlD
Desipramine—HTR1A—brain—brain cancer	0.000401	0.00202	CbGeAlD
Desipramine—Rash—Carmustine—brain cancer	0.0004	0.00194	CcSEcCtD
Desipramine—HRH1—endocrine gland—brain cancer	0.0004	0.00201	CbGeAlD
Desipramine—Dermatitis—Carmustine—brain cancer	0.0004	0.00193	CcSEcCtD
Desipramine—Headache—Carmustine—brain cancer	0.000398	0.00192	CcSEcCtD
Desipramine—SLC6A2—brain—brain cancer	0.000398	0.002	CbGeAlD
Desipramine—HRH1—head—brain cancer	0.000395	0.00199	CbGeAlD
Desipramine—Vomiting—Temozolomide—brain cancer	0.00039	0.00189	CcSEcCtD
Desipramine—Urticaria—Etoposide—brain cancer	0.00039	0.00189	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—brain cancer	0.000388	0.00188	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—brain cancer	0.000388	0.00188	CcSEcCtD
Desipramine—Rash—Temozolomide—brain cancer	0.000387	0.00187	CcSEcCtD
Desipramine—Dermatitis—Temozolomide—brain cancer	0.000387	0.00187	CcSEcCtD
Desipramine—CYP2E1—endocrine gland—brain cancer	0.000384	0.00193	CbGeAlD
Desipramine—Headache—Temozolomide—brain cancer	0.000384	0.00186	CcSEcCtD
Desipramine—HTR2A—midbrain—brain cancer	0.00038	0.00191	CbGeAlD
Desipramine—CYP2E1—head—brain cancer	0.00038	0.00191	CbGeAlD
Desipramine—Nausea—Carmustine—brain cancer	0.000377	0.00182	CcSEcCtD
Desipramine—HTR2A—spinal cord—brain cancer	0.000371	0.00187	CbGeAlD
Desipramine—CYP2B6—central nervous system—brain cancer	0.000369	0.00186	CbGeAlD
Desipramine—Nausea—Temozolomide—brain cancer	0.000365	0.00176	CcSEcCtD
Desipramine—DRD2—brain—brain cancer	0.000362	0.00182	CbGeAlD
Desipramine—HRH1—central nervous system—brain cancer	0.000361	0.00181	CbGeAlD
Desipramine—Asthenia—Etoposide—brain cancer	0.000352	0.0017	CcSEcCtD
Desipramine—Pruritus—Etoposide—brain cancer	0.000347	0.00168	CcSEcCtD
Desipramine—ABCB1—telencephalon—brain cancer	0.000347	0.00175	CbGeAlD
Desipramine—CYP2E1—central nervous system—brain cancer	0.000346	0.00174	CbGeAlD
Desipramine—CYP2E1—cerebellum—brain cancer	0.000339	0.0017	CbGeAlD
Desipramine—SLC22A5—brain—brain cancer	0.000338	0.0017	CbGeAlD
Desipramine—Diarrhoea—Etoposide—brain cancer	0.000336	0.00162	CcSEcCtD
Desipramine—HTR2A—endocrine gland—brain cancer	0.000334	0.00168	CbGeAlD
Desipramine—HTR2A—head—brain cancer	0.00033	0.00166	CbGeAlD
Desipramine—Dizziness—Etoposide—brain cancer	0.000325	0.00157	CcSEcCtD
Desipramine—Vomiting—Etoposide—brain cancer	0.000312	0.00151	CcSEcCtD
Desipramine—Rash—Etoposide—brain cancer	0.00031	0.0015	CcSEcCtD
Desipramine—CYP3A4—endocrine gland—brain cancer	0.000309	0.00156	CbGeAlD
Desipramine—Dermatitis—Etoposide—brain cancer	0.000309	0.0015	CcSEcCtD
Desipramine—Headache—Etoposide—brain cancer	0.000308	0.00149	CcSEcCtD
Desipramine—CYP2D6—endocrine gland—brain cancer	0.000304	0.00153	CbGeAlD
Desipramine—HTR2A—central nervous system—brain cancer	0.000301	0.00151	CbGeAlD
Desipramine—CYP2D6—head—brain cancer	0.000301	0.00151	CbGeAlD
Desipramine—HTR2A—cerebellum—brain cancer	0.000294	0.00148	CbGeAlD
Desipramine—CYP2B6—brain—brain cancer	0.000293	0.00147	CbGeAlD
Desipramine—Nausea—Etoposide—brain cancer	0.000292	0.00141	CcSEcCtD
Desipramine—ABCB1—gonad—brain cancer	0.00029	0.00146	CbGeAlD
Desipramine—HRH1—brain—brain cancer	0.000286	0.00144	CbGeAlD
Desipramine—ABCB1—pituitary gland—brain cancer	0.000283	0.00142	CbGeAlD
Desipramine—CYP3A4—central nervous system—brain cancer	0.000279	0.0014	CbGeAlD
Desipramine—CYP2E1—brain—brain cancer	0.000275	0.00138	CbGeAlD
Desipramine—CYP2D6—central nervous system—brain cancer	0.000274	0.00138	CbGeAlD
Desipramine—ABCB1—medulla oblongata—brain cancer	0.000273	0.00137	CbGeAlD
Desipramine—CYP2D6—cerebellum—brain cancer	0.000268	0.00135	CbGeAlD
Desipramine—ABCB1—midbrain—brain cancer	0.000249	0.00125	CbGeAlD
Desipramine—ABCB1—spinal cord—brain cancer	0.000243	0.00122	CbGeAlD
Desipramine—HTR2A—brain—brain cancer	0.000239	0.0012	CbGeAlD
Desipramine—ABCB1—endocrine gland—brain cancer	0.000219	0.0011	CbGeAlD
Desipramine—CYP2D6—brain—brain cancer	0.000218	0.0011	CbGeAlD
Desipramine—ABCB1—head—brain cancer	0.000216	0.00109	CbGeAlD
Desipramine—ABCB1—central nervous system—brain cancer	0.000197	0.000992	CbGeAlD
Desipramine—ABCB1—cerebellum—brain cancer	0.000193	0.00097	CbGeAlD
Desipramine—ABCB1—brain—brain cancer	0.000157	0.000788	CbGeAlD
Desipramine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IRS2—brain cancer	1.89e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.88e-05	0.000136	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—IDH1—brain cancer	1.87e-05	0.000136	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.87e-05	0.000135	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.86e-05	0.000135	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.86e-05	0.000135	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ENO2—brain cancer	1.85e-05	0.000134	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HES1—brain cancer	1.85e-05	0.000134	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.85e-05	0.000134	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.83e-05	0.000133	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HES1—brain cancer	1.81e-05	0.000131	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VAV1—brain cancer	1.81e-05	0.000131	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IRS2—brain cancer	1.81e-05	0.000131	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—IL2—brain cancer	1.79e-05	0.00013	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.78e-05	0.000129	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VAV1—brain cancer	1.77e-05	0.000129	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HES1—brain cancer	1.77e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VAV1—brain cancer	1.77e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VAV1—brain cancer	1.76e-05	0.000128	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PDGFRA—brain cancer	1.76e-05	0.000128	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HES1—brain cancer	1.76e-05	0.000128	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—IL2—brain cancer	1.75e-05	0.000127	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.75e-05	0.000127	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ENO2—brain cancer	1.75e-05	0.000127	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PDGFRA—brain cancer	1.72e-05	0.000125	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.71e-05	0.000124	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SPP1—brain cancer	1.71e-05	0.000124	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.71e-05	0.000124	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.69e-05	0.000122	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—BSG—brain cancer	1.68e-05	0.000122	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.68e-05	0.000122	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SPP1—brain cancer	1.67e-05	0.000121	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—APC—brain cancer	1.67e-05	0.000121	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1.67e-05	0.000121	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SPP1—brain cancer	1.64e-05	0.000119	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.63e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL2—brain cancer	1.63e-05	0.000118	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—APC—brain cancer	1.6e-05	0.000116	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	1.6e-05	0.000116	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL2—brain cancer	1.59e-05	0.000115	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL2—brain cancer	1.56e-05	0.000113	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CG—brain cancer	1.56e-05	0.000113	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000113	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL2—brain cancer	1.55e-05	0.000112	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IRS2—brain cancer	1.55e-05	0.000112	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HES1—brain cancer	1.53e-05	0.000111	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HES1—brain cancer	1.53e-05	0.000111	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.52e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HES1—brain cancer	1.52e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.52e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HES1—brain cancer	1.52e-05	0.00011	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IRS2—brain cancer	1.51e-05	0.00011	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.000109	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HES1—brain cancer	1.5e-05	0.000109	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.48e-05	0.000107	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000107	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IRS2—brain cancer	1.48e-05	0.000107	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ENO2—brain cancer	1.48e-05	0.000107	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.48e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000107	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IRS2—brain cancer	1.47e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000106	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.46e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.44e-05	0.000105	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—IDH1—brain cancer	1.44e-05	0.000105	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000104	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.43e-05	0.000104	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CG—brain cancer	1.43e-05	0.000104	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SPP1—brain cancer	1.41e-05	0.000102	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SPP1—brain cancer	1.41e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SPP1—brain cancer	1.41e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SPP1—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SPP1—brain cancer	1.39e-05	0.000101	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL2—brain cancer	1.37e-05	9.91e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—APC—brain cancer	1.37e-05	9.91e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	1.37e-05	9.91e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.35e-05	9.75e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL2—brain cancer	1.34e-05	9.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CG—brain cancer	1.34e-05	9.71e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL2—brain cancer	1.34e-05	9.7e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—APC—brain cancer	1.34e-05	9.69e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CG—brain cancer	1.34e-05	9.69e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL2—brain cancer	1.33e-05	9.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL2—brain cancer	1.32e-05	9.58e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—APC—brain cancer	1.31e-05	9.48e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.31e-05	9.48e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—RELA—brain cancer	1.3e-05	9.44e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—APC—brain cancer	1.3e-05	9.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.3e-05	9.43e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IRS2—brain cancer	1.3e-05	9.42e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—ERBB2—brain cancer	1.29e-05	9.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.28e-05	9.27e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IRS2—brain cancer	1.28e-05	9.25e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IRS2—brain cancer	1.27e-05	9.22e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IRS2—brain cancer	1.27e-05	9.19e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IRS2—brain cancer	1.26e-05	9.1e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—RELA—brain cancer	1.25e-05	9.04e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—EGFR—brain cancer	1.24e-05	9.03e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—ERBB2—brain cancer	1.24e-05	8.98e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—EGFR—brain cancer	1.22e-05	8.83e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.19e-05	8.63e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL2—brain cancer	1.17e-05	8.5e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.15e-05	8.35e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—APC—brain cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CCND1—brain cancer	1.14e-05	8.28e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO2—brain cancer	1.14e-05	8.27e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	8.2e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—APC—brain cancer	1.13e-05	8.19e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.13e-05	8.19e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CG—brain cancer	1.13e-05	8.18e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.13e-05	8.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—APC—brain cancer	1.13e-05	8.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	8.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—APC—brain cancer	1.12e-05	8.14e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL2—brain cancer	1.12e-05	8.14e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	8.12e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—APC—brain cancer	1.12e-05	8.12e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.11e-05	8.04e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—APC—brain cancer	1.11e-05	8.04e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CCND1—brain cancer	1.09e-05	7.93e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	7.86e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—RELA—brain cancer	1.07e-05	7.74e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ERBB2—brain cancer	1.06e-05	7.69e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.05e-05	7.58e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—RELA—brain cancer	1.04e-05	7.57e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ERBB2—brain cancer	1.04e-05	7.52e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.03e-05	7.46e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—brain cancer	1.03e-05	7.44e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—brain cancer	1.02e-05	7.42e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—RELA—brain cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—brain cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—RELA—brain cancer	1.02e-05	7.37e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.01e-05	7.36e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—brain cancer	1.01e-05	7.32e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.01e-05	7.32e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—brain cancer	9.96e-06	7.22e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—brain cancer	9.86e-06	7.15e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL2—brain cancer	9.62e-06	6.97e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—brain cancer	9.54e-06	6.92e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—brain cancer	9.45e-06	6.85e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL2—brain cancer	9.41e-06	6.82e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CCND1—brain cancer	9.37e-06	6.8e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	9.28e-06	6.73e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL2—brain cancer	9.2e-06	6.67e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—brain cancer	9.17e-06	6.65e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—brain cancer	9.17e-06	6.64e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL2—brain cancer	9.15e-06	6.63e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CTNNB1—brain cancer	9.08e-06	6.58e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—RELA—brain cancer	8.97e-06	6.5e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—brain cancer	8.97e-06	6.5e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—brain cancer	8.96e-06	6.5e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—brain cancer	8.92e-06	6.47e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ERBB2—brain cancer	8.91e-06	6.46e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.88e-06	6.44e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.83e-06	6.4e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—RELA—brain cancer	8.82e-06	6.4e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—RELA—brain cancer	8.8e-06	6.38e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—brain cancer	8.78e-06	6.36e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—RELA—brain cancer	8.78e-06	6.36e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.77e-06	6.36e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ERBB2—brain cancer	8.75e-06	6.34e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—RELA—brain cancer	8.75e-06	6.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ERBB2—brain cancer	8.72e-06	6.32e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CG—brain cancer	8.7e-06	6.31e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ERBB2—brain cancer	8.69e-06	6.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—RELA—brain cancer	8.66e-06	6.28e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ERBB2—brain cancer	8.61e-06	6.24e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—brain cancer	8.59e-06	6.22e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CG—brain cancer	8.5e-06	6.16e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—brain cancer	8.17e-06	5.92e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—brain cancer	8.09e-06	5.87e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2—brain cancer	8.08e-06	5.85e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CG—brain cancer	8.01e-06	5.8e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—brain cancer	7.99e-06	5.8e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—brain cancer	7.95e-06	5.76e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—brain cancer	7.93e-06	5.75e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—brain cancer	7.92e-06	5.74e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—brain cancer	7.9e-06	5.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—brain cancer	7.88e-06	5.71e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—brain cancer	7.87e-06	5.71e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.82e-06	5.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—brain cancer	7.8e-06	5.66e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.8e-06	5.65e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.78e-06	5.64e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—brain cancer	7.75e-06	5.62e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—brain cancer	7.74e-06	5.61e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—brain cancer	7.73e-06	5.6e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—brain cancer	7.7e-06	5.59e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—brain cancer	7.7e-06	5.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—brain cancer	7.68e-06	5.57e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.67e-06	5.56e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.65e-06	5.55e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	7.63e-06	5.53e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—brain cancer	7.61e-06	5.51e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	7.61e-06	5.51e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	7.53e-06	5.46e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—brain cancer	7.53e-06	5.46e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—brain cancer	7.52e-06	5.45e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—brain cancer	7.36e-06	5.33e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—brain cancer	7.35e-06	5.33e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—brain cancer	7.21e-06	5.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—brain cancer	7.19e-06	5.22e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—brain cancer	7.19e-06	5.21e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—brain cancer	7.16e-06	5.19e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—brain cancer	7.03e-06	5.1e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—brain cancer	7e-06	5.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—brain cancer	6.86e-06	4.98e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—brain cancer	6.8e-06	4.93e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—brain cancer	6.78e-06	4.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.75e-06	4.9e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—brain cancer	6.74e-06	4.89e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.72e-06	4.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—brain cancer	6.7e-06	4.85e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—brain cancer	6.69e-06	4.85e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—brain cancer	6.67e-06	4.84e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—brain cancer	6.65e-06	4.82e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—brain cancer	6.63e-06	4.81e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—brain cancer	6.63e-06	4.81e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—brain cancer	6.57e-06	4.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—brain cancer	6.31e-06	4.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—brain cancer	6.21e-06	4.5e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—brain cancer	6.2e-06	4.49e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—brain cancer	6.18e-06	4.48e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—brain cancer	6.18e-06	4.48e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—brain cancer	6.18e-06	4.48e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—brain cancer	6.16e-06	4.47e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—brain cancer	6.1e-06	4.42e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—brain cancer	6.08e-06	4.41e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—brain cancer	6.06e-06	4.4e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—brain cancer	6.04e-06	4.38e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—brain cancer	6.04e-06	4.38e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—brain cancer	6.03e-06	4.37e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—brain cancer	5.97e-06	4.33e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—brain cancer	5.91e-06	4.28e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—brain cancer	5.88e-06	4.26e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—brain cancer	5.23e-06	3.79e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—brain cancer	5.19e-06	3.76e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—brain cancer	5.1e-06	3.7e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—brain cancer	5.09e-06	3.69e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—brain cancer	5.08e-06	3.68e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—brain cancer	5.06e-06	3.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—brain cancer	5.01e-06	3.63e-05	CbGpPWpGaD
